Gedeon Richter PLC (BUD:RICHTER)

Market Cap	1.96T +1.6%
Revenue (ttm)	901.32B +7.4%
Net Income	227.29B +7.4%
EPS	1,241.29 +7.3%
Shares Out	182.38M
PE Ratio	8.68
Forward PE	7.30
Dividend	508.56 (4.88%)
Ex-Dividend Date	Jun 3, 2025

Volume	398,414
Average Volume	238,416
Open	10,620
Previous Close	10,610
Day's Range	10,620 - 10,870
52-Week Range	9,380 - 11,150
Beta	0.22
RSI	64.19
Earnings Date	Feb 27, 2026

About Gedeon Richter

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic ...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 10,943
• Stock Exchange: Budapest Stock Exchange
• Ticker Symbol: RICHTER

Financial Performance

In 2024, Gedeon Richter's revenue was 857.55 billion, an increase of 6.51% compared to the previous year's 805.16 billion. Earnings were 239.24 billion, an increase of 50.61%.